Company / Current Assets per Share
Aclaris Therapeutics, Inc. Current Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.89
FY2025
5-year range
$0.89 / $4.55
FY2021-FY2025
Trend
-49.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has declined for 4 consecutive years, from $4.55 in FY2021 to $0.89 in FY2025.
Based on SEC 10-K filings.
0.89 in FY2025 with a 5-year CAGR of -8.4%.
Declined from $1.93 to $0.89 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -38.2%
- 5-Year CAGR
- -8.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- Aclaris Therapeutics, Inc.'s current assets per share has declined for 4 consecutive years.
- In FY2025, current assets per share decreased 49.7% year-over-year.
- Peak current assets per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.89 | -49.7% |
| FY2024 | $1.78 | -8.1% |
| FY2023 | $1.93 | -48.9% |
| FY2022 | $3.78 | -16.8% |
| FY2021 | $4.55 | +228.0% |
| FY2020 | $1.39 | -31.8% |
| FY2019 | $2.03 | -65.0% |
| FY2018 | $5.82 | -24.3% |
| FY2017 | $7.68 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026